Search Within

Gary Ulaner

Formats
  1. Journal Article (95)
  2. Meeting Abstract (39)
  3. Miscellaneous (5)
  4. Review (4)
  5. Editorial (2)
  6. Book Whole (1)
  7. Guidelines (1)
Groups
  1. Molecular Imaging and Therapy Service (147)
  2. Radiology, Department of (147)
  3. Department of Medicine (75)
  4. Solid Tumor Oncology Division (60)
  5. GSK Faculty (59)
  6. Epidemiology and Biostatistics (46)

More Groups

People
  1. David Hyman (22)
  2. Christopher Riedl (21)
  3. Maxine Jochelson (21)
  4. Jason Lewis (20)
  5. Maura Dickler (19)
  6. Komal Jhaveri (18)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (12)
  6. 2020 (21)

More Years

Publications
  1. Journal of Nuclear Medicine (24)
  2. Clinical Nuclear Medicine (23)
  3. Journal of Clinical Oncology (16)
  4. Cancer Research (8)
  5. PET Clinics (7)
  6. European Journal of Nuclear Medicine and Molecular Imaging (6)

More Publications

Publishers
  1. Lippincott Williams & Wilkins (27)
  2. Society of Nuclear Medicine (24)
  3. American Society of Clinical Oncology (16)
  4. Elsevier Inc. (16)
  5. American Association for Cancer Research (12)
  6. Springer (8)

More Publishers

Results (147)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular imaging of biomarkers in breast cancer
    Journal Article

    Ulaner, G. A.; Riedl, C. C.; Dickler, M. N.; Jhaveri, K.; Pandit-Taskar, N.; Weber, W.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Prognostic value of FDG PET/CT before allogeneic and autologous stem cell transplantation for aggressive lymphoma
    Journal Article

    Ulaner, G. A.; Goldman, D. A.; Sauter, C. S.; Migliacci, J.; Lilienstein, J.; Gönen, M.; Schöder, H.; Moskowitz, C. H.; Zelenetz, A. D.
    Radiology (2015)

    Fulltext@MSK | Save
  • Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma
    Journal Article

    Hogan, M. P.; Goldman, D. A.; Dashevsky, B.; Riedl, C. C.; Gönen, M.; Osborne, J. R.; Jochelson, M.; Hudis, C.; Morrow, M.; Ulaner, G. A.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Detection of internal mammary adenopathy in patients with breast cancer by PET/CT and MRI
    Journal Article

    Jochelson, M. S.; Lebron, L.; Jacobs, S. S.; Zheng, J.; Moskowitz, C. S.; Powell, S. N.; Sacchini, V.; Ulaner, G. A.; Morris, E. A.; Dershaw, D. D.
    American Journal of Roentgenology (2015)

    Fulltext@MSK | Save
  • Predictive value of positron emission tomography/computed tomography to assess early treatment response to dual human epidermal growth factor receptor 2 (HER2) blockade without chemotherapy for HER2-positive metastatic breast cancer: Are we ready to embrace this "early metabolic look" strategy?
    Journal Article

    Jhaveri, K.; Ulaner, G. A.; Dickler, M. N.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Appearance of untreated bone metastases from breast cancer on FDG PET/CT: Importance of histologic subtype
    Journal Article

    Dashevsky, B. Z.; Goldman, D. A.; Parsons, M.; Gönen, M.; Corben, A. D.; Jochelson, M. S.; Hudis, C. A.; Morrow, M.; Ulaner, G. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save
  • Validation of target engagement using 18F-fluoroestradiol PET in patients undergoing therapy with selective estrogen receptor degrader, ARN-810 (GDC-0810)
    Meeting Abstract

    Wang, Y. B.; Ulaner, G.; Manning, H. C.; Bardia, A.; Mayer, I.; Dickler, M.; Maneval, E. C.; Lewis, J.; Baselga, J.; Mahmood, U.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of FDG-PET/CT with contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients: A retrospective analysis
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M.; Ulaner, G.; Mcarthur, H.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • How does the number of lesions analyzed impact response assessment with PERCIST in breast cancer?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M.; Ulaner, G.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save